Eisai Faces Stock Decline Amid Anticipation for Upcoming Financial Report and Strong Leqembi Revenue Projections
Eisai Co., Ltd. is preparing to release its financial report, with analysts projecting a decline in earnings per share, but the company is also expecting robust revenue from its Alzheimer’s treatment, Leqembi.
2 minutes to read